297
Participants
Start Date
April 30, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
December 31, 2012
Reyataz + Norvir + Truvada
atazanavir 300mg + ritonavir 100mg + tenofovir 300mg/emtricitabine 200mg
Reyataz + Epzicom
atazanavir 400mg + abacavir 600mg/lamivudine 300mg
GSK Investigational Site, Valhalla
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Lynchburg
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Charlotte
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Savannah
GSK Investigational Site, Daytona Beach
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami Beach
GSK Investigational Site, Wilton Manors
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Ft. Pierce
GSK Investigational Site, Hobson City
GSK Investigational Site, Memphis
GSK Investigational Site, Berkeley
GSK Investigational Site, East Lansing
GSK Investigational Site, Minneapolis
GSK Investigational Site, Chicago
GSK Investigational Site, Kansas City
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Denver
GSK Investigational Site, Boise
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Los Angeles
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Long Beach
GSK Investigational Site, San Diego
GSK Investigational Site, Newport Beach
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Bakersfield
GSK Investigational Site, San Francisco
GSK Investigational Site, Oakland
GSK Investigational Site, Spokane
GSK Investigational Site, Hillsborough
GSK Investigational Site, Newark
GSK Investigational Site, Ponce
GSK Investigational Site, San Juan
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY